Novartis AG is 36.8x more valuable than Abivax S.A. by market capitalization ($283.13 B vs $7.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABVX | NVS |
|---|---|---|
| Market cap | $7.70 B | $283.13 B |
| US-listed rank | #1093 | #47 |
| SEC filings | 92 | 947 |
Novartis AG is 36.8x more valuable than Abivax S.A. by market capitalization ($283.13 B vs $7.70 B).
Full pages: Abivax S.A. and Novartis AG, or browse the full rankings.